Sangeeta B. Joshi

5.0k total citations
148 papers, 3.6k citations indexed

About

Sangeeta B. Joshi is a scholar working on Molecular Biology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sangeeta B. Joshi has authored 148 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Biology, 54 papers in Infectious Diseases and 39 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sangeeta B. Joshi's work include Protein purification and stability (61 papers), Monoclonal and Polyclonal Antibodies Research (39 papers) and Viral gastroenteritis research and epidemiology (36 papers). Sangeeta B. Joshi is often cited by papers focused on Protein purification and stability (61 papers), Monoclonal and Polyclonal Antibodies Research (39 papers) and Viral gastroenteritis research and epidemiology (36 papers). Sangeeta B. Joshi collaborates with scholars based in United States, India and United Kingdom. Sangeeta B. Joshi's co-authors include C. Russell Middaugh, David B. Volkin, Reza Esfandiary, Ozan S. Kumru, Tim J. Kamerzell, John M. Hickey, David D. Weis, Steven M. Bishop, Feng He and Santosh V. Thakkar and has published in prestigious journals such as Nature Communications, Analytical Chemistry and Advanced Drug Delivery Reviews.

In The Last Decade

Sangeeta B. Joshi

144 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sangeeta B. Joshi United States	31	2.3k	1.1k	701	504	352	148	3.6k
Jafar Amani Iran	30	1.6k 0.7×	329 0.3×	587 0.8×	574 1.1×	222 0.6×	197	3.1k
Roberto Adamo Italy	36	2.1k 0.9×	475 0.4×	638 0.9×	518 1.0×	905 2.6×	102	3.6k
David B. Volkin United States	50	5.0k 2.2×	2.0k 1.9×	1.1k 1.5×	1.1k 2.1×	537 1.5×	189	7.2k
Krystyna Dąbrowska Poland	38	1.5k 0.7×	1.0k 1.0×	844 1.2×	394 0.8×	434 1.2×	94	4.3k
Chung‐Yi Wu Taiwan	44	3.3k 1.4×	658 0.6×	588 0.8×	873 1.7×	922 2.6×	124	5.4k
Jeremy P. Derrick United Kingdom	34	2.8k 1.2×	647 0.6×	482 0.7×	412 0.8×	575 1.6×	119	4.3k
Stefania Conti Italy	31	1.4k 0.6×	393 0.4×	1.0k 1.5×	689 1.4×	1.0k 2.9×	181	4.0k
Kenneth E. Palmer United States	33	1.5k 0.7×	282 0.3×	787 1.1×	446 0.9×	480 1.4×	84	3.3k
Richard J. O’Callaghan United States	36	1.4k 0.6×	398 0.4×	716 1.0×	435 0.9×	388 1.1×	128	3.6k
Mariusz Skwarczyński Australia	42	2.8k 1.2×	386 0.4×	797 1.1×	1.9k 3.8×	566 1.6×	162	5.4k

Countries citing papers authored by Sangeeta B. Joshi

Since Specialization

Citations

This map shows the geographic impact of Sangeeta B. Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sangeeta B. Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sangeeta B. Joshi more than expected).

Fields of papers citing papers by Sangeeta B. Joshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sangeeta B. Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sangeeta B. Joshi. The network helps show where Sangeeta B. Joshi may publish in the future.

Co-authorship network of co-authors of Sangeeta B. Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Sangeeta B. Joshi. A scholar is included among the top collaborators of Sangeeta B. Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sangeeta B. Joshi. Sangeeta B. Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kumar, Prashant, et al.. (2024). Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges. Vaccines. 12(6). 609–609.

Hickey, John M., Nitya Sharma, Sarah A. Brendle, et al.. (2024). A Combined LC-MS and Immunoassay Approach to Characterize Preservative-Induced Destabilization of Human Papillomavirus Virus-like Particles Adsorbed to an Aluminum-Salt Adjuvant. Vaccines. 12(6). 580–580. 1 indexed citations

Weidenbacher, Payton A., Mrinmoy Sanyal, Natalia Friedland, et al.. (2023). A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates. Nature Communications. 14(1). 2149–2149. 54 indexed citations

Kumru, Ozan S., Mark S. Klempner, Yang Wang, et al.. (2023). Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coli. Journal of Pharmaceutical Sciences. 112(7). 1832–1844. 1 indexed citations

Wan, Ying, Ozan S. Kumru, Swathi R. Pullagurla, et al.. (2022). Multi-Dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part I - Screening of Preservative Combinations. Journal of Pharmaceutical Sciences. 112(2). 446–457. 4 indexed citations

Teh, Audrey Y‐H., Lisa A. Cavacini, Yue Hu, et al.. (2021). Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli , expressed as secretory IgA1 and IgA2 in plants. Gut Microbes. 13(1). 15 indexed citations

Gupta, Vineet, Ozan S. Kumru, Richard Pospíšil, et al.. (2021). Development of a high-throughput RT-PCR based viral infectivity assay for monitoring the stability of a replicating recombinant Lymphocytic Choriomeningitis viral vector. Journal of Virological Methods. 301. 114440–114440. 2 indexed citations

Kaur, Kawaljit, John M. Hickey, Sanjeev Agarwal, et al.. (2020). Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens. Journal of Pharmaceutical Sciences. 110(3). 1042–1053. 12 indexed citations

Iyer, Vidyashankara, Weiqiang Cheng, Sangeeta B. Joshi, et al.. (2014). High Throughput Prediction of the Long-Term Stability of Pharmaceutical Macromolecules from Short-Term Multi-Instrument Spectroscopic Data. Journal of Pharmaceutical Sciences. 103(3). 828–839. 25 indexed citations

10.

Kumru, Ozan S., et al.. (2014). Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies. Biologicals. 42(5). 237–259. 285 indexed citations

11.

Hickey, John M., Kathleen M. Holtz, Prakash Manikwar, et al.. (2014). Mechanism of a Decrease in Potency for the Recombinant Influenza A Virus Hemagglutinin H3 Antigen During Storage. Journal of Pharmaceutical Sciences. 103(3). 821–827. 14 indexed citations

12.

Dickenson, Nicholas E., Shyamal P. Choudhari, Ryan M. Kramer, et al.. (2013). Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon. Protein Science. 22(5). 614–627. 40 indexed citations

13.

Choudhari, Shyamal P., Ryan M. Kramer, Michael L. Barta, et al.. (2013). Studies of the conformational stability of invasion plasmid antigen B from Shigella. Protein Science. 22(5). 666–670. 7 indexed citations

14.

Zeng, Yuhong, Lisa A. Kueltzo, Richard Schwartz, et al.. (2013). Development of a Stable Virus-Like Particle Vaccine Formulation against Chikungunya Virus and Investigation of the Effects of Polyanions. Journal of Pharmaceutical Sciences. 102(12). 4305–4314. 19 indexed citations

15.

Wang, Tingting, Ozan S. Kumru, Jennifer Zhang, et al.. (2013). Effect of Ionic Strength and pH on the Physical and Chemical Stability of a Monoclonal Antibody Antigen-Binding Fragment. Journal of Pharmaceutical Sciences. 102(8). 2520–2537. 49 indexed citations

16.

Hu, Lei, Sangeeta B. Joshi, Santosh V. Thakkar, et al.. (2012). Comparison of the Structural Stability and Dynamic Properties of Recombinant Anthrax Protective Antigen and its 2-Fluorohistidine-Labeled Analogue. Journal of Pharmaceutical Sciences. 101(11). 4118–4128. 14 indexed citations

17.

Esfandiary, Reza, et al.. (2010). Formulation and Immunogenicity of a Potential Multivalent Type III Secretion System-Based Protein Vaccine. Journal of Pharmaceutical Sciences. 99(11). 4497–4509. 13 indexed citations

18.

Brooks, Amanda E., et al.. (2008). Properties of Synthetic Spider Silk Fibers Based on Argiope aurantia MaSp2. Biomacromolecules. 9(6). 1506–1510. 69 indexed citations

19.

Ausar, Salvador F., Chad S. Braun, Stephen P. Cape, et al.. (2008). Stabilization of measles virus for vaccine formulation. Human Vaccines. 4(5). 350–359. 51 indexed citations

20.

Joshi, Sangeeta B., et al.. (2007). The Interaction of Heparin/polyanions with Bovine, Porcine, and Human Growth Hormone**Sangeeta B. Joshi and Tim J. Kamerzell contributed equally to this work.. Journal of Pharmaceutical Sciences. 97(4). 1368–1385. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact